MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,397,000 | +95.4% | 20,000 | +310.5% | 0.08% | +211.5% |
| Q4 2021 | $715,000 | -73.1% | 4,872 | -67.5% | 0.03% | -67.9% |
| Q3 2021 | $2,654,000 | -58.4% | 15,000 | -62.0% | 0.08% | -59.3% |
| Q2 2021 | $6,384,000 | +23.2% | 39,522 | +30.7% | 0.20% | +34.5% |
| Q1 2021 | $5,180,000 | +135.9% | 30,242 | +202.4% | 0.15% | +85.0% |
| Q4 2020 | $2,196,000 | -43.6% | 10,000 | -80.0% | 0.08% | -88.0% |
| Q3 2019 | $3,896,000 | +65.4% | 50,000 | 0.0% | 0.67% | +34.5% |
| Q3 2018 | $2,355,000 | – | 50,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |